[Treatment of extrapyramidal adverse effects in neuroleptic therapy].
D000208:Acute Disease; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002908:Chronic Disease; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced*; D014149:Tranquilizing Agents / Q000009:adverse effects*
D000978:Antiparkinson Agents; D014149:Tranquilizing Agents
Behandling av extrapyramidala biverkningar vid nerolptikabehandlung.